SCHEMBL27809709

SCHEMBL27809709

C=Cc1ccc(N(C)O[SH](=O)=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ HDAC8 Q9BY41 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ CYP2A13 Q16696 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ HSD17B3 P37058 1/20 0.31
▸ APP P05067 1/20 0.31
▸ CHRNB2 P17787 1/20 0.30
▸ CHRNB4 P30926 1/20 0.30
▸ CHRNA3 P32297 1/20 0.30
▸ CHRNA7 P36544 1/20 0.30
▸ CHRNA4 P43681 1/20 0.30
▸ MEN1 O00255 2/20 0.30
▸ MAPT P10636 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ TRPA1 O75762 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ CASP1 P29466 1/20 0.30
▸ BRCA1 P38398 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27297501 0.83 CYP2A6 (0.55) ALDH1A1CYP2A6CYP2A13TSHRHSD17B3
SCHEMBL28168182 0.76 ALDH1A1 (0.46) ALDH1A1TDP1TSHRCHRNA7MEN1
SCHEMBL17772909 0.76 ALDH1A1 (0.48) ALDH1A1HDAC8CYP2A6CYP2A13TDP1
SCHEMBL27700429 0.75 ALDH1A1 (0.41) ALDH1A1CYP2A6TDP1TSHRCHRNB2
SCHEMBL27450285 0.75 TDP1 (0.48) ALDH1A1TDP1TSHRMEN1MAPT
SCHEMBL28168179 0.75 APP (0.39) ALDH1A1TDP1APPMEN1MAPT
SCHEMBL27294646 0.74 HTT (0.43) ALDH1A1TSHRCHRNB2CHRNB4CHRNA3
SCHEMBL27350154 0.71 — —
SCHEMBL178888 0.71 CYP2A6 (0.58) ALDH1A1CYP2A6CYP2A13TDP1TSHR
Hydrochloric Acid SCHEMBL2806293 0.69 CYP2A6 (0.56) ALDH1A1CYP2A6CYP2A13TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102448920-A Antiviral compounds and uses thereof ABBOTT LAB 2012-05-09 — — CN disclosed
CN-101918369-A Uracil or thymine derivatives for the treatment of hepatitis C ABBOTT LAB 2010-12-15 — — CN disclosed
CN-101801935-A Uracil or thymine derivatives for the treatment of hepatitis C ABBOTT LAB 2010-08-11 — — CN disclosed
Send feedback